The treatment of epilepsy in developing countries: where do we go from here?

Epilepsy is the most common serious neurological disorder and is one of the world?s most prevalent noncommunicable diseases. As the understanding of its physical and social burden has increased it has moved higher up the world health agenda. Over four-fifths of the 50 million people with epilepsy ar...

Full description

Saved in:
Bibliographic Details
Main Authors: Scott Robert A. (Author), Lhatoo Samden D. (Author), Sander Josemir W.A.S (Author)
Format: Book
Published: The World Health Organization, 2001-01-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_08df8c3bf9e443f5b0d253e1990c8fb6
042 |a dc 
100 1 0 |a Scott Robert A.  |e author 
700 1 0 |a Lhatoo Samden D.  |e author 
700 1 0 |a Sander Josemir W.A.S.  |e author 
245 0 0 |a The treatment of epilepsy in developing countries: where do we go from here? 
260 |b The World Health Organization,   |c 2001-01-01T00:00:00Z. 
500 |a 0042-9686 
520 |a Epilepsy is the most common serious neurological disorder and is one of the world?s most prevalent noncommunicable diseases. As the understanding of its physical and social burden has increased it has moved higher up the world health agenda. Over four-fifths of the 50 million people with epilepsy are thought to be in developing countries; much of this condition results from preventable causes. Around 90% of people with epilepsy in developing countries are not receiving appropriate treatment. Consequently, people with epilepsy continue to be stigmatized and have a lower quality of life than people with other chronic illnesses. However, bridging the treatment gap and reducing the burden of epilepsy is not straightforward and faces many constraints. Cultural attitudes, a lack of prioritization, poor health system infrastructure, and inadequate supplies of antiepileptic drugs all conspire to hinder appropriate treatment. Nevertheless, there have been successful attempts to provide treatment, which have shown the importance of community-based approaches and also indicate that provision for sustained intervention over the long term is necessary in any treatment programme. Approaches being adopted in the demonstration projects of the Global Campaign Against Epilepsy - implemented by the International League Against Epilepsy, the International Bureau for Epilepsy, and the World Health Organization - may provide further advances. Much remains to be done but it is hoped that current efforts will lead to better treatment of people with epilepsy in developing countries. 
546 |a EN 
690 |a Epilepsy/drug therapy 
690 |a Epilepsy/epidemiology 
690 |a Anticonvulsants/supply and distribution 
690 |a Phenobarbital/therapeutic use 
690 |a Cost of illness 
690 |a Clinical protocols 
690 |a Sustainability 
690 |a Developing countries 
690 |a Public aspects of medicine 
690 |a RA1-1270 
655 7 |a article  |2 local 
786 0 |n Bulletin of the World Health Organization, Vol 79, Iss 4, Pp 344-351 (2001) 
787 0 |n http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S0042-96862001000400012 
787 0 |n https://doaj.org/toc/0042-9686 
856 4 1 |u https://doaj.org/article/08df8c3bf9e443f5b0d253e1990c8fb6  |z Connect to this object online.